D Delgado-Bellido, FJ Oliver… - International Journal of …, 2023 - mdpi.com
Tumor growth depends on the vascular system, either through the expansion of blood vessels or novel adaptation by tumor cells. One of these novel pathways is vasculogenic …
W Zhang, F Wang, L Yin, Y Tang… - Journal of Cellular …, 2024 - Wiley Online Library
Our study was conducted to investigate whether cadherin‐5 (CDH5), a vascular endothelial cell adhesion glycoprotein, could facilitate the differentiation of human induced pluripotent …
Y Liu, G Li, J Ning, Y Zhao - Oncology Letters, 2024 - spandidos-publications.com
Abstract Ginsenoside Rg3 (GS‑Rg3), a sterol molecule isolated from ginseng, has demonstrated various immunological properties, including inhibition of cancer cell …
M Monteagudo, B Calsina, ME Salazar-Hidalgo… - Best Practice & …, 2024 - Elsevier
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours. Around 20- 25% of patients develop metastases, for which there is an urgent need of prognostic markers …
J Li, Z Lu, L Xu, J Wang, S Qian, Q Hu… - ACS Applied Bio …, 2024 - ACS Publications
Hindlimb ischemia is a common disease worldwide featured by the sudden decrease in limb perfusion, which usually causes a potential threat to limb viability and even amputation or …
L Wu, J Xiao, D Yi, H Ding, R Wang, Z Duan… - Journal of Translational …, 2024 - Springer
Background Although the long-term prognosis of papillary thyroid cancer (PTC) is favorable, distant metastasis significantly compromises the prognosis and quality of life for patients with …
Background: We have previously reported that endothelial-to-mesenchymal transition (EndMT) is an active process in patients with idiopathic pulmonary fibrosis (IPF) contributing …
Human-induced pluripotent stem cell (hiPSC)-derived cardiomyocytes raise the possibility of generating pluripotent stem cells from a wide range of human diseases. In the cardiology …
Q Shuai, X Xu, Y Liang, Z Halbiyat, X Lu… - Bioengineering & …, 2024 - Wiley Online Library
Vasculogenic mimicry (VM) describes a process by which tumor cells formed a novel microcirculation pattern in an endothelial cell‐free manner. Clinically, VM is associated with …